Clinical Trial Update: A Phase Ⅲ Efficacy and Safety Study of Hemay005 in Subjects With Moderate to Severe Plaque Psoriasis [Phase 3]

View source ↗

Summary

Phase 3 trial updates for Hemay005 in moderate to severe plaque psoriasis have been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Hemay005

Snippet

Sponsor: Tianjin Hemay Pharmaceutical Co., Ltd | Conditions: Psoriasis | Phase 3 | Status: COMPLETED